Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Total Revenue
144,372
136,110
127,342
133,841
Cost of Revenue
102,696
94,816
84,684
84,499
Gross Profit
41,676
41,294
42,658
49,342
Operating Expenses
Research Development
7,441
6,906
8,940
9,436
Selling General and Administrative
22,147
17,421
21,308
22,214
Non Recurring
--
--
--
--
Others
0
0
0
0
Total Operating Expenses
29,588
24,327
30,248
31,650
Operating Income or Loss
12,088
16,967
12,410
17,692
Income from Continuing Operations
Total Other Income/Expenses Net
(14,167)
(497)
(3,488)
(7,628)
Earnings Before Interest And Taxes
(2,079)
16,470
8,922
10,064
Interest Expense
16,177
16,694
19,292
20,194
Income Before Tax
(18,256)
(224)
(10,370)
(10,130)
Income Tax Expense
(1,664)
(5,308)
1,787
(2,544)
Minority Interest
--
--
--
--
Net Income From Continuing Ops
(16,592)
5,084
(12,157)
(7,586)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(16,592)
5,084
(12,157)
(7,586)
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(16,592)
5,084
(12,157)
(7,586)